Zapamwamba Zapamwamba za Glybenzcyclamide za Pharmaceutical Synthesis

Ku Jiangsu Jingye Pharmaceutical Co., Ltd., ndife onyadira kukhala bwenzi lodalirika pazamankhwala padziko lonse lapansi. Monga opanga apadera opanga mankhwala opangira mankhwala ndi zapakati, timamvetsetsa gawo lofunikira lomweGlybenzcyclamide Intermediatesewera pakukula ndi kupanga mankhwala —makamaka pochiza matenda amtundu wa 2.

Sitimangopanga mankhwala. Timapereka zodalirika, zabwino, komanso mtendere wamalingaliro kumakampani opanga mankhwala padziko lonse lapansi.

Chifukwa Chake Glybenzcyclamide Yathu Yapakati Imaonekera

Glybenzcyclamide Intermediates ndi mankhwala ofunikira popanga mankhwala a sulfonylurea-class anti-diabetes, kuphatikiza Glibenclamide. Makhalidwe apakati awa amakhudza mwachindunji mphamvu ndi chitetezo cha mankhwala omaliza a mankhwala.

Ku Jiangsu Jingye Pharmaceutical, flagship yathu yapakati—4-(2-aminoethyl)benzenesulfonamide—amapangidwa motsatira malamulo okhwima okhwima. Nthawi zonse imakwaniritsa miyezo iyi:

Kuyera ≥99%, kutsimikiziridwa ndi njira zapamwamba zowunikira (HPLC, GC, NMR)

Kukhazikika kwabwino komanso kusasinthika, ngakhale pamagulu akuluakulu opanga

Thandizo lathunthu loyang'anira, kuphatikiza COA, MSDS, ndi ndondomeko ya data

Kupezeka kosinthika kwa R&D, oyendetsa, komanso zofunikira pazamalonda

Posankha Glybenzcyclamide Intermediates, makasitomala athu amapindula ndi kaphatikizidwe kosalala, zolephera zochepa, komanso maziko owongolera olimba.

Zatsopano Zili mu DNA Yathu

Malo athu ali ndi zida zamakono komanso ogwira ntchito ndi gulu laukadaulo lophunzitsidwa bwino. Timapitiriza kukhathamiritsa njira zathu kuti tiwonetsetse kuti apakatikati athu akwaniritsa zofunikira zamakampani opanga mankhwala.

Sitikuyimira pa zomwe tikuyembekezera - timaziposa. R&D yathu yapanyumba imatilola kupereka upangiri wa kaphatikizidwe ndi kapangidwe kwa makasitomala omwe akufuna mayankho ogwirizana. Kaya mukupanga generic version kapena kupanga molekyulu yatsopano yamankhwala, titha kuthandiza gulu lanu ndi Glybenzcyclamide Intermediates yodalirika.

Wothandizira Amene Mungakhulupirire

Kwa zaka zambiri, tapanga ubale wolimba ndi makampani opanga mankhwala ku Europe, Asia, ndi America. Othandizana nawo padziko lonse lapansi amadalira ife pa:

Kutumiza pa nthawi, ngakhale pa nthawi yochepa

Mitengo yampikisano, popanda kunyengerera pamtundu

Kulankhulana momvera, ndi chithandizo chonse chaukadaulo komanso chowongolera

M'modzi mwamakasitomala athu aku Europe, wopanga mankhwala amtundu wapakatikati, adakweza zokolola zawo ndi 18% atasinthira ku Glybenzcyclamide Intermediates. Izi zidasinthidwa kukhala ndalama zopulumutsira pachaka zopitilira $200,000 ndikuchepetsa kwambiri malipoti opotoka owongolera.

Timakhulupirira kuti izi ndi momwe mgwirizano weniweni umawonekera: kukula kwapawiri kutengera kukhulupirirana ndi ntchito.

Kupanga Mwanzeru Kwa Dziko Lathanzi

Monga kampani yopanga mankhwala, timamvetsetsa udindo wathu kwa odwala komanso dziko lapansi. Malo athu opangira zinthu amatsatira miyezo ya GMP, ISO9001, ndi REACH. Kuonjezera apo, tikuchita nawo ntchito zobiriwira zobiriwira, pofuna kuchepetsa zinyalala komanso kuwononga chilengedwe pa gawo lililonse la ndondomeko yathu.

Makhalidwe athu amawonetsetsa kuti gulu lililonse la Glybenzcyclamide Intermediates limapangidwa motetezeka, mwalamulo, komanso mokhazikika.

Gwirani Ntchito Nafe

Ife ku Jiangsu Jingye Pharmaceutical Co., Ltd. ndife oposa ogulitsa Glybenzcyclamide Intermediates. Ndife othandizana nawo pakupanga mankhwala otetezeka komanso ogwira mtima. Kuchokera pachiyero chapamwamba mpaka kuperekedwa kodalirika komanso kutsata malamulo, timapereka zomwe mukuyembekezera komanso ntchito zomwe zikuyenera.

Pitani patsamba lathu la kampani kuti mudziwe zambiri za omwe ndife, kapena kuwona zomwe tatulutsa, 4-(2-aminoethyl)benzenesulfonamide, kuti muwone momwe tingathandizire kupanga kwanu kotsatira.

Tiyeni timange tsogolo lazatsopano zamankhwala—limodzi.